Formal Name
Inhibin B Infertility, Serum
This article was last reviewed on
This article waslast modified on December 4, 2020.
At a Glance
Why Get Tested?

You may get tested as part of an infertility evaluation, along with other testing.

(For inhibin A testing during pregnancy, see Maternal Serum Screening, Second Trimester.)

When To Get Tested?

When you and your partner are having trouble getting pregnant (infertility); sometimes prior to some assisted reproductive procedures, such as in-vitro fertilization

Sample Required?

A blood sample drawn from a vein

Test Preparation Needed?

None; however, follow any instructions from your healthcare practitioner or the lab performing the testing. If you are a woman, your blood sample may need to be drawn at a particular time during your menstrual cycle, such as on day three.

What is being tested?

Inhibin B is a hormone associated with reproduction and the development of eggs in women and sperm in men. This test measures the inhibin B level in the blood and may be used as part of an infertility evaluation.

Inhibin B is made mostly by the ovaries in females, and by the testicles in males.

  • In women, inhibin B is associated with maturation of follicles in the ovaries. The follicles are the structures that develop into mature eggs. Inhibin B rises and falls at different times during each menstrual cycle.
  • In men, inhibin B plays a role in the production of sperm in the testicles. Inhibin B levels are typically higher in men with normal fertility compared to men who do not produce an adequate number of viable sperm.

These roles allow inhibin B tests to be used as a marker of remaining fertility and ovarian function in women. Less commonly, it can be used to assess fertility in men.

Women are born with a fixed number of follicles within the ovaries that can mature to become eggs. This maturation process occurs during each of your menstrual cycles. As you age, you have fewer viable follicles and so produce fewer mature eggs. Over time, the quality of the eggs decreases as well, and they are more likely to have chromosome imbalances. Levels of inhibin B and another hormone called anti-Müllerian hormone (AMH) correlate with the number of follicles you have remaining, so they are a general indicator of remaining fertility (ovarian reserve). If you are going to have assisted reproductive procedures such as in-vitro fertilization, then inhibin B and AMH levels are related to your likely responsiveness to treatment.

Accordion Title
Common Questions
View Sources

Makanji, Y. et. al. (2014 July 22). Inhibin at 90: From Discovery to Clinical Application, a Historical Review. Endocr Rev. 2014 Oct; 35(5): 747–794. Available online at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4167436/. Accessed on 09/26/2020.

Dave, C. et. al. (2020 June 5, Updated). Male Infertility. Medscape Urology. Available online at https://emedicine.medscape.com/article/436829-overview. Accessed on 09/26/2020.

Michener, C. (2020 January 23, Updated). Ovarian Dysgerminomas. Medscape Obstetrics & Gynecology. Available online at https://emedicine.medscape.com/article/253701-overview. Accessed on 09/26/2020.

(© 1995–2020). Inhibin B, Serum. Mayo Clinic Laboratories. Available online at https://www.mayocliniclabs.com/test-catalog/Clinical+and+Interpretive/88722. Accessed on 09/26/2020.

Jabbour, S. (2020 April 1, Updated). Follicle-Stimulating Hormone Abnormalities. Medscape Endocrinology. Available online at https://emedicine.medscape.com/article/118810-overview. Accessed on 09/26/2020.

Jacobson, J. et. al. (2020 September 16, Updated). Quadruple screen test. MedlinePlus Medical Encyclopedia. Available online at https://medlineplus.gov/ency/article/007311.htm. Accessed on 09/26/2020.

Lawrenz, B. et. al. (2020 May 15). Inhibin A-A Promising Predictive Parameter for Determination of Final Oocyte Maturation in Ovarian Stimulation for IVF/ICSI. Front Endocrinol (Lausanne). 2020 May 15;11:307. Available online at https://pubmed.ncbi.nlm.nih.gov/32499758/. Accessed on 09/26/2020.

Knudtson, J and McLaughlin, J. (2019 March). Female Reproductive Endocrinology. Merck Manual Professional Version. Available online at https://www.merckmanuals.com/professional/gynecology-and-obstetrics/female-reproductive-endocrinology/female-reproductive-endocrinology. Accessed on 09/26/2020.

Morley, J. (2019 March, Updated). Overview of the Endocrine System. Merck Manual Professional Version. Available online at https://www.merckmanuals.com/professional/endocrine-and-metabolic-disorders/principles-of-endocrinology/overview-of-the-endocrine-system. Accessed on 09/26/2020.

Hazard, F. (2019 December 23, Updated). Ovarian Dysgerminomas Pathology Overview of Ovarian Dysgerminomas. Medscape Pathology. Available online at https://emedicine.medscape.com/article/1951026-overview#a1. Accessed on 09/26/2020.

Demyashkin, G. (2018 June 9). Inhibin B in seminiferous tubules of human testes in normal spermatogenesis and in idiopathic infertility. Syst Biol Reprod Med. 2019 Feb;65(1):20-28. Available online at https://pubmed.ncbi.nlm.nih.gov/29886763/. Accessed on 09/26/2020.

Kaufman, J. et. al. (2019 March 19). Aging and the Male Reproductive System. Endocrine Reviews, Volume 40, Issue 4, August 2019, Pages 906–972. Available online at https://academic.oup.com/edrv/article/40/4/906/5381905?searchresult=1. Accessed on 09/26/2020.

Anderson, R. et. al. (2018 July 02). Gonadotropins and Their Analogs: Current and Potential Clinical Applications. Endocrine Reviews, Volume 39, Issue 6, December 2018, Pages 911–937. Available online at https://academic.oup.com/edrv/article/39/6/911/5047286?searchresult=1. Accessed on 09/26/2020.

Allshouse, A. (2018 October 25). Menstrual cycle hormone changes associated with reproductive aging and how they may relate to symptoms. Obstet Gynecol Clin North Am. 2018 Dec; 45(4): 613–628.Available online at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6226272/. Accessed on 09/26/2020.

Ask a Laboratory Scientist

This form enables patients to ask specific questions about lab tests. Your questions will be answered by a laboratory scientist as part of a voluntary service provided by one of our partners, American Society for Clinical Laboratory Science. Please allow 2-3 business days for an email response from one of the volunteers on the Consumer Information Response Team.

Country
Disclaimer
Thank you for using the Consumer Information Response Service ("the Service") to inquire about the meaning of your lab test results.  The Service is provided free of charge by the American Society for Clinical Laboratory Science, which is one of many laboratory organizations that supports Lab Tests Online.
Please note that information provided through this free Service is not intended to be medical advice and should not be relied on as such. Although the laboratory provides the largest single source of objective, scientific data on patient status, it is only one part of a complex biological picture of health or disease. As professional clinical laboratory scientists, our goal is to assist you in understanding the purpose of laboratory tests and the general meaning of your laboratory results. It is important that you communicate with your physician so that together you can integrate the pertinent information, such as age, ethnicity, health history, signs and symptoms, laboratory and other procedures (radiology, endoscopy, etc.), to determine your health status. The information provided through this Service is not intended to substitute for such consultations with your physician nor specific medical advice to your health condition.
By submitting your question to this Service, you agree to waive, release, and hold harmless the American Society for Clinical Laboratory Science and its affiliates or their past or present officers, directors, employees, agents, and Service volunteers (collectively referred to as "ASCLS") and the American Association  for Clinical Chemistry and its affiliates or their past or present officers, directors, employees, agents, and Service volunteers (collectively referred to as "AACC") from any legal claims, rights, or causes of action you may have in connection with the responses provided to the questions that you submit to the Service.
AACC, ASCLS and its Service volunteers disclaim any liability arising out of your use of this Service or for any adverse outcome from your use of the information provided by this Service for any reason, including but not limited to any misunderstanding or misinterpretation of the information provided through this Service.